FdaApplication

ANDA 204774

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSCIEGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2015-12-07

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN150MGTABLET;ORAL
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL

3 products